In the News
BranchLab Raises $26M Series A Led by McKesson Ventures to Bring AI to Pharma Commercialization
AI-based biopharma commercialization company BranchLab recently announced the completion of a $26 million Series-A funding round, led by McKesson Ventures and with additional participation from FCA Venture Partners, Sanofi Ventures, and AIX Ventures, bringing the company’s total funding to $35 million. With this new...
Atropos Health CEO Brigham Hyde Discusses Healthcare and Medical Technology Trends With McKesson Ventures Partner Michelle Snyder on Breaking Health Podcast
Michelle Snyder, McKesson Ventures’ Partner and host of the Breaking Health podcast, recently spoke with Atropos Health CEO and co-founder Brigham Hyde, PhD on an episode of the show. Snyder interviewed Hyde about impressive movements that companies have been making in the healthcare and medical technology...
Latent Raises $80M to Close the Gap Between Diagnosis and Treatment
Clinical-AI innovation company Latent recently announced the completion of a $80M Series A funding round, led by Spark Capital and Transformation Capital, along with participation from Conviction, McKesson Ventures, General Catalyst, and Y Combinator. This new capital will allow the company to continue expanding upon...
Midi Health Surpasses $1B Valuation, Igniting a New Era for Women’s Health
Premier midlife women’s healthcare company Midi Health announced that it has officially surpassed a $1 billion valuation—the first company in its field to achieve this incredible milestone. The company’s latest funding round included a number of new investors, including Serena Ventures, Goodwater Capital, and...
Oath Surgical Announces AI-Native Surgical Centers Powered by NVIDIA
AI-based surgical care innovator Oath Surgical has announced that it will be partnering with NVIDIA to increase support for the OathOS clinical intelligence platform through the use of NVIDIA’s advanced spatial AI infrastructure. This will supply surgeons in Oath’s AI-native surgical centers with real-time analysis...
Atropos Health Announces AI-Driven Commercial Analytics Solution for Life Science Companies
Real-world clinical data provider Atropos Health has announced that it will be making its Commercial Analytics solutions available to life science leaders. This new offering will harness the speed, accuracy, and efficiency of the company’s AI-powered ChatRWD® application—providing users with the ability to generate...
Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking
Biotechnology research and life sciences dealmaking company Prudentia Sciences recently announced that it has secured $20 million in Series A financing, led by McKesson Ventures with participation from SignalFire. This newest investment brings Prudentia’s total funding to $27 million and will be used to further the...
Reimagine Care and Tampa General Hospital Cancer Institute Launch Virtual Cancer Care Collaboration to Reduce Hospitalizations and Elevate Patient Support
Technology-enabled cancer care provider Reimagine Care recently announced that it has entered into a collaboration with the Tampa General Hospital (TGH) Cancer Institute, in which the two will be expanding access and increasing quality of care for oncology treatment throughout Tampa Bay, Florida. This will be...
Midi Health CEO Joanna Strober Discusses Accessible Menopause Care with McKesson Ventures Partner Michelle Snyder on Breaking Health Podcast
Joanna Strober, CEO and founder of women’s midlife care provider Midi Health, recently was featured on Episode 176 of the Breaking Health Podcast, alongside host and McKesson Ventures partner Michelle Snyder. The two discussed how Midi is providing a platform for robust and equitable healthcare to women all across...
Atropos Health Launches the Atropos Evidence™ Agent with Microsoft Teams to Surface Personalized Evidence during Multidisciplinary Care Team Collaborations
Real-world data-based healthcare technology company Atropos Health recently announced the launch of an integration between the company’s Atropos Evidence™ Agent and Microsoft Teams. This agent allows for real-world evidence (RWE) to be generated at the touch of a button—to be used by medical providers to gain...